| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |